Showing results (2301-2310 of 8,982) with videos related to

Sort By:
Pageof 899
Journal of Hepatology|October 12, 2010
Sub-clinical hepatic encephalopathy in cirrhotic patients is not aggravated by sedation with propofol compared to midazolam: a randomized controlled studyIyad Khamaysi, Nseir William, Alexandrov Olga, et al.
Journal of Hepatology|October 13, 2010
Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathwayWen-Qing Xiang, Wen-Feng Feng, Wei Ke, et al.
Journal of Hepatology|March 1, 2011
A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturationPaul C Adams, James C Barton
Journal of Hepatology|March 1, 2011
Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patientsEdward J Gane, Regine Rouzier, Catherine Stedman, et al.
Journal of Hepatology|March 1, 2011
Alpha-fetoprotein-thymidine kinase-luciferase knockin mice: a novel model for dual modality longitudinal imaging of tumorigenesis in liverXincheng Lu, Hong Guo, Joseph Molter, et al.
Journal of Hepatology|February 23, 2011
Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitisM I Lucena, N Kaplowitz, H Hallal, et al.
Journal of Hepatology|February 22, 2011
Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver diseaseTomoyoshi Soga, Masahiro Sugimoto, Masashi Honma, et al.
Journal of Hepatology|February 22, 2011
Genetic variability in the methylenetetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson's diseaseGrażyna Gromadzka, Magdalena Rudnicka, Grzegorz Chabik, et al.
Journal of Hepatology|July 27, 2019
Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infectionSuzanne Faure-Dupuy, Marion Delphin, Ludovic Aillot, et al.
Journal of Hepatology|July 15, 2019
Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis: A case report of 3 patientsAlessandro Loglio, Peter Ferenci, Sara Colonia Uceda Renteria, et al.
Pageof 899